New ESCMID-ECMM-ERS clinical guidelines for aspergillosis released
May 02 2018
New guidelines for aspergillosis have been released by the European Society for Clinical Microbiology and Infectious Diseases, the European Confederation of Medical Mycology and the European Respiratory.
Candida auris outbreak in ICU traced back to contaminated axillary thermometers (UK)
April 30 2018
A 66-patient outbreak of the emerging pathogen Candida auris in an ICU was traced back to multi-use equipment, in particular axillary thermometers, which was halted when the thermometers were removed. For patients known to have a C. auris infection, the CDC recommend clinicians to use standard and contact precautions plus an EPA-registered disinfectant that is effective against Clostridium spores, in order to prevent transmission to other patients.
Large European study highlights the importance of post-HSCT prophylaxis in minimising candidaemia
April 24 2018
An international study of more than 28,500 acute leukaemia patients found that around 1.2% developed candidaemia in the first 100 days following HSCT (median 22 days), with a fatality rate of 22%.
Burden of fungal disease in Sweden and Benin presented at ECCMID as GAFFI annual report released
April 23 2018
GAFFI's 2017 annual report was released to coincide with the ECCMID 2018 conference in Madrid, where burden of disease data from Sweden and Benin are being presented. Notable milestones this year included the acceptance of chromoblastomycosis as a WHO Neglected Tropical Disease and the addition of itraconazole, voriconazole and topical natamycin to the WHO Essential Medicines List.
Tinea incognito linked to inappropriate prescribing of corticosteroid-containing creams
April 18 2018
Dr Bornali Dutta and colleagues in Assam (India) recently called for stronger regulation of triple therapy creams containing a corticosteroid, an antifungal and an antibacterial, which are often prescribed inappropriately by pharmacists. The steroid component is responsible for changing many cases of simple dermatophyte infections into chronic cases of tinea incognito that require treatment with topical and systemic antifungals.